Source: Carnegie Mellon University
Date: November 2, 2007
Summary:
Scientists at Carnegie Mellon University are using adult neural stem cells to develop a new stem-based drug delivery therapy that may ultimately help treat a variety of inherited disorders like Hunter syndrome. They are creating genetically engineered adult neural stem cells for delivery to patients' brains, where they will be programmed to produce an essential missing protein.
